What does PHARMACIE LAMBION-LAMALLE do?

PHARMACIE LAMBION-LAMALLE is a pharmacy in Liège. Private Limited, started on 16 December 1999, 1 establishment.

What is the address of PHARMACIE LAMBION-LAMALLE?

The registered office of PHARMACIE LAMBION-LAMALLE is located at Rue Fraischamps 162, 4030 Liège.

Is PHARMACIE LAMBION-LAMALLE still active?

Yes. According to the CBE (1 October 2026) PHARMACIE LAMBION-LAMALLE is active, legal situation “Normale toestand”, started on 16 December 1999.

Is PHARMACIE LAMBION-LAMALLE registered on Peppol?

Yes, PHARMACIE LAMBION-LAMALLE is registered on the Peppol network with ID 0208:0468344605.

What is the enterprise number of PHARMACIE LAMBION-LAMALLE?

The enterprise number of PHARMACIE LAMBION-LAMALLE is BE0468344605.

When was PHARMACIE LAMBION-LAMALLE founded?

PHARMACIE LAMBION-LAMALLE was founded on 16 December 1999.

Who are the directors of PHARMACIE LAMBION-LAMALLE?

According to the 2025 annual accounts, the directors of PHARMACIE LAMBION-LAMALLE are: Hugues LAMBION, Anne LAMALLE.

Is PHARMACIE LAMBION-LAMALLE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 16 December 1999; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did PHARMACIE LAMBION-LAMALLE make in 2025?

PHARMACIE LAMBION-LAMALLE posted a profit after taxes of € 191,229 in financial year 2025.

What is the revenue of PHARMACIE LAMBION-LAMALLE?

As a small company, PHARMACIE LAMBION-LAMALLE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 524,362.

How much does an employee at PHARMACIE LAMBION-LAMALLE earn?

The average wage cost per full-time employee at PHARMACIE LAMBION-LAMALLE was € 57,900 in 2025: staff costs of € 208,306 for 3.6 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does PHARMACIE LAMBION-LAMALLE have?

According to the 2025 annual accounts, PHARMACIE LAMBION-LAMALLE has 3.6 full-time equivalents (FTE).

PHARMACIE LAMBION-LAMALLE (Private Limited) - Liège

Dossier PHARMACIE LAMBION-LAMALLE, printed on 1 October 2026 from databakkes.be/en/0468344605/pharmacie-lambion-lamalle. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

PHARMACIE LAMBION-LAMALLE from Liège, company number BE0468344605, closed financial year 2025 with a result of € 191,229 after tax. For that financial year PHARMACIE LAMBION-LAMALLE recorded a gross margin of € 524,362 and equity of € 1.1 million. Compared with financial year 2024, the result moved from € 171,635 to € 191,229. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on May 19, 2026.

What it is worth Growing

€ 1.1 million

▲ 13% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 191,229

▲ 11% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 496,568

▲ € 383,655 vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 63,666 paid out

33 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents

3.6

▲ 0.4 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 208,306

▲ 11% vs 2024

€ 57,900 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 40,626

▲ € 32,422 vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 122,400

▼ 20% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 70,134

▲ 22% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 439,723 Gross margin 2022: € 439,723 First fiscal year in the series	€ 486,846 Gross margin 2023: € 486,846 ▲ 11% vs 2022 (€ 439,723) Favourable step	€ 469,444 Gross margin 2024: € 469,444 ▼ 4% vs 2023 (€ 486,846) Unfavourable step	€ 524,362 Gross margin 2025: € 524,362 ▲ 12% vs 2024 (€ 469,444) Favourable step	▲ 12%
Profit after taxes	€ 150,432 Profit after taxes 2022: € 150,432 First fiscal year in the series	€ 168,803 Profit after taxes 2023: € 168,803 ▲ 12% vs 2022 (€ 150,432) Favourable step	€ 171,635 Profit after taxes 2024: € 171,635 ▲ 2% vs 2023 (€ 168,803) Favourable step	€ 191,229 Profit after taxes 2025: € 191,229 ▲ 11% vs 2024 (€ 171,635) Favourable step	▲ 11%
Equity	€ 745,968 Equity 2022: € 745,968 First fiscal year in the series	€ 850,012 Equity 2023: € 850,012 ▲ 14% vs 2022 (€ 745,968) Favourable step	€ 952,981 Equity 2024: € 952,981 ▲ 12% vs 2023 (€ 850,012) Favourable step	€ 1,080,545 Equity 2025: € 1,080,545 ▲ 13% vs 2024 (€ 952,981) Favourable step	▲ 13%
Total debts	€ 357,857 Total debts 2022: € 357,857 First fiscal year in the series	€ 201,987 Total debts 2023: € 201,987 ▼ 44% vs 2022 (€ 357,857) Favourable step	€ 212,076 Total debts 2024: € 212,076 ▲ 5% vs 2023 (€ 201,987) Unfavourable step	€ 194,201 Total debts 2025: € 194,201 ▼ 8% vs 2024 (€ 212,076) Favourable step	▼ 8%
Cash	€ 362,913 Cash 2022: € 362,913 First fiscal year in the series	€ 196,663 Cash 2023: € 196,663 ▼ 46% vs 2022 (€ 362,913) Unfavourable step	€ 112,913 Cash 2024: € 112,913 ▼ 43% vs 2023 (€ 196,663) Unfavourable step	€ 496,568 Cash 2025: € 496,568 ▲ € 383,655 vs 2024 (€ 112,913) Favourable step	▲ € 383,655
Land & buildings	€ 201,332 Land & buildings 2022: € 201,332 First fiscal year in the series	€ 190,087 Land & buildings 2023: € 190,087 ▼ 6% vs 2022 (€ 201,332) Unchanged	€ 178,843 Land & buildings 2024: € 178,843 ▼ 6% vs 2023 (€ 190,087) Unchanged	€ 167,599 Land & buildings 2025: € 167,599 ▼ 6% vs 2024 (€ 178,843) Unchanged	▼ 6%
Retained profit	€ 739,768 Retained profit 2022: € 739,768 First fiscal year in the series	€ 843,812 Retained profit 2023: € 843,812 ▲ 14% vs 2022 (€ 739,768) Favourable step	€ 946,781 Retained profit 2024: € 946,781 ▲ 12% vs 2023 (€ 843,812) Favourable step	€ 1,074,345 Retained profit 2025: € 1,074,345 ▲ 13% vs 2024 (€ 946,781) Favourable step	▲ 13%
Dividend	€ 49,600 Dividend 2022: € 49,600 First fiscal year in the series	€ 61,666 Dividend 2023: € 61,666 ▲ 24% vs 2022 (€ 49,600) Unchanged	€ 68,666 Dividend 2024: € 68,666 ▲ 11% vs 2023 (€ 61,666) Unchanged	€ 63,666 Dividend 2025: € 63,666 ▼ 7% vs 2024 (€ 68,666) Unchanged	▼ 7%
Bank debt	€ 65,161 Bank debt 2022: € 65,161 First fiscal year in the series	€ 2,988 Bank debt 2023: € 2,988 ▼ 95% vs 2022 (€ 65,161) Favourable step	€ 0 Bank debt 2024: € 0 ▼ 100% vs 2023 (€ 2,988) Favourable step	€ 0 Bank debt 2025: € 0 Unchanged (€ 0) Unchanged
Balance sheet total	€ 1,103,825 Balance sheet total 2022: € 1,103,825 First fiscal year in the series	€ 1,052,000 Balance sheet total 2023: € 1,052,000 ▼ 5% vs 2022 (€ 1,103,825) Unchanged	€ 1,165,058 Balance sheet total 2024: € 1,165,058 ▲ 11% vs 2023 (€ 1,052,000) Unchanged	€ 1,274,745 Balance sheet total 2025: € 1,274,745 ▲ 9% vs 2024 (€ 1,165,058) Unchanged	▲ 9%
Employees (FTE)	2.5 Employees (FTE) 2022: 2.5 First fiscal year in the series	3 Employees (FTE) 2023: 3 ▲ 0.5 vs 2022 (2.5) Unchanged	3.2 Employees (FTE) 2024: 3.2 ▲ 0.2 vs 2023 (3) Unchanged	3.6 Employees (FTE) 2025: 3.6 ▲ 0.4 vs 2024 (3.2) Unchanged	▲ 0.4

Key figures of PHARMACIE LAMBION-LAMALLE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to PHARMACIE LAMBION-LAMALLE?

What happened at PHARMACIE LAMBION-LAMALLE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

May 19, 2026 New annual accounts for financial year 2025: profit of € 191,229 (▲ 11% vs 2024). Source: NBB ↗
Jan 28, 2000 New establishment in Liège. KBO
Dec 16, 1999 Start of the company according to the CBE. KBO

In short

From € 150,432 profit in 2022 to € 191,229 profit in 2025.

Paid € 253,131 in corporate taxes since 2022.

Best year ever: 2025, with € 191,229 profit.

On average € 145,700 of value added per employee in 2025.

Original PDFs at the National Bank ↗

A new publication or filing at PHARMACIE LAMBION-LAMALLE? We notify you, reason included.

Follow PHARMACIE LAMBION-LAMALLE

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Hugues LAMBION Anne LAMALLE

PHARMACIE LAMBION-LAMALLE

Behind PHARMACIE LAMBION-LAMALLE are Hugues LAMBION and Anne LAMALLE.

See the full network in the app

Directors

According to the 2025 annual accounts

Hugues LAMBION

Director

Anne LAMALLE

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Rue Fraischamps 162

4030 Liège

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0468.344.605

VAT number

BE 0468.344.605

Registered office

Rue Fraischamps 162, 4030 Liège

Names & denominations

PHARMACIE LAMBION-LAMALLE

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

16 December 1999

Peppol

Active · Active since 4 Nov 2025

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

PHARMACIE LAMBION-LAMALLE

Financials

What happened to PHARMACIE LAMBION-LAMALLE?

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions